CD34 and neoplasm: In most cases of UESL, tumor cells demonstrate positivity for vimentin and α1-antitrypsin, along with variable expression of cytokeratin, desmin, α-smooth muscle actin (SMA), muscle-specific actin, CD68, myoglobin, nonspecific enolase, S100, and CD34 (25, 26).